This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

Initial Dosing Strategies for Long-Acting Injectable Risperidone

Mark W. Viner, MD; Jeremy M. Matuszak, MD; and Linda J. Knight, MD

Published: August 1, 2006

Article Abstract

Sir: What are the most effective initial dosing strategies when starting long-acting injectable risperidone? Vials are available in 3 doses: 25, 37.5, and 50 mg. As clinicians continue to gain experience in prescribing risperidone in this new injectable form, a review of initial dosing strategies when starting a patient on long-acting injectable risperidone is needed.’ ‹


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 67

Quick Links: Dementia , Neurologic and Neurocognitive

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Clinical and Practical Psychopharmacology

Antipsychotic Augmentation With N-Acetylcysteine for Patients With Schizophrenia

Dr Andrade discusses whether or not recent findings support the use of NAC as antipsychotic augmentation in...

Read More...